Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1965 1
1967 1
1970 6
1971 2
1972 1
1973 5
1974 6
1975 2
1976 2
1977 4
1978 6
1979 5
1980 5
1981 3
1982 4
1983 2
1984 3
1985 3
1986 7
1987 3
1988 1
1990 4
1991 3
1992 4
1993 7
1994 6
1995 9
1996 4
1997 7
1998 5
1999 13
2000 7
2001 6
2002 9
2003 9
2004 8
2005 8
2006 3
2008 14
2009 8
2010 9
2011 15
2012 15
2013 15
2014 11
2015 8
2016 4
2017 3
2018 5
2019 4
2020 8
2021 13
2022 11
2023 12
2024 8

Text availability

Article attribute

Article type

Publication date

Search Results

323 results

Results by year

Filters applied: . Clear all
Page 1
Baricitinib in juvenile idiopathic arthritis: an international, phase 3, randomised, double-blind, placebo-controlled, withdrawal, efficacy, and safety trial.
Ramanan AV, Quartier P, Okamoto N, Foeldvari I, Spindler A, Fingerhutová Š, Antón J, Wang Z, Meszaros G, Araújo J, Liao R, Keller S, Brunner HI, Ruperto N; JUVE-BASIS investigators; Paediatric Rheumatology International Trials Organisation. Ramanan AV, et al. Lancet. 2023 Aug 12;402(10401):555-570. doi: 10.1016/S0140-6736(23)00921-2. Epub 2023 Jul 6. Lancet. 2023. PMID: 37423231 Clinical Trial.
Is DOPA a neurotransmitter?
Misu Y, Goshima Y, Miyamae T. Misu Y, et al. Among authors: miyamae t. Trends Pharmacol Sci. 2002 Jun;23(6):262-8. doi: 10.1016/s0165-6147(02)02013-8. Trends Pharmacol Sci. 2002. PMID: 12084631 Review.
Anti-nuclear matrix protein 2 antibody-positive inflammatory myopathies represent extensive myositis without dermatomyositis-specific rash.
Ichimura Y, Konishi R, Shobo M, Inoue S, Okune M, Maeda A, Tanaka R, Kubota N, Matsumoto I, Ishii A, Tamaoka A, Shimbo A, Mori M, Morio T, Kishi T, Miyamae T, Tanboon J, Inoue M, Nishino I, Fujimoto M, Nomura T, Okiyama N. Ichimura Y, et al. Among authors: miyamae t. Rheumatology (Oxford). 2022 Mar 2;61(3):1222-1227. doi: 10.1093/rheumatology/keab518. Rheumatology (Oxford). 2022. PMID: 34152410
Juvenile fibromyalgia: Guidance for management.
Yokota S, Kikuchi M, Miyamae T. Yokota S, et al. Among authors: miyamae t. Pediatr Int. 2013 Aug;55(4):403-9. doi: 10.1111/ped.12155. Pediatr Int. 2013. PMID: 23758613 Review.
323 results